Abstract

In this work, the synthesis and biological activity of a new series of piperazine-hydrazone derivatives have been reported. The titled compounds were prepared in good yields from 1-methylpiperazine and 2-chloro-5-nitropyridine as starting materials via a five-step process. The newly synthesized compounds were fully characterized using spectral analyses such as IR, 1H NMR, 13C NMR, and MS spectra. Furthermore, DFT (density functional theory) calculations were performed to better understand the molecular geometry and electronic properties of the synthesized compounds. The primary antimicrobial activity of all synthesized compounds was evaluated against four pathogenic microorganisms. As a result, compound 6 was identified as the best candidate for selectively inhibiting Candida krusei. Compound 7e was also found to be a good inhibitor of Bacillus subtilis and Candida krusei. Docking studies revealed that compounds 6 and 7e exhibit good affinity for the active site of sterol 14-alpha demethylase (CYP51) of Candida krusei, which may explain their promising antimicrobial activity.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.